港股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

医药外包概念

2,031.892

+131.6846.93%

涨家数：7

跌家数：1

平家数：- -

市盈率：- -

高：2,042.768

开：1,900.358

低：1,900.358

收：1,900.208

数据加载中...

CXO行业复苏龙头泰格医药为何“落后”了？

GPLP犀牛财经

三生国健：GJ-613新药上市申请获受理

智飞生物：15价肺炎球菌结合疫苗申请生产注册获受理

药明生物：授出合共6.41万股受限制股份奖励计划受限制股份

格隆汇资讯

药明康德上交所回购47万A股金额2999万元

恒瑞医药：枸橼酸钠血滤置换液获得药品注册批准

福元医药(601089.SH)：酮洛芬贴剂获得药物临床试验批准通知书

舒泰神：注射用STSP-0601纳入优先审评程序

泰格医药06月05日主力净流出109.2万元散户资金买入

金斯瑞生物科技06月05日主力净流入1827.0万元散户资金抛售

维亚生物06月05日遭主力抛售223.9万元

中证香港300内地高贝塔指数报917.76点，前十大权重包含药明生物等

昭衍新药盘中异动下午盘大幅跳水5.12%

百奥赛图-B涨超5% 第二代全人IGF-1R抗体NTB003获中国临床试验许可

中银国际：升信达生物目标价至82港元维持“买入”评级

里昂：和黄医药赛沃替尼研究数据向好维持“跑赢大市”评级

美媒称中国生物技术正快速崛起

港股异动 | 中国同辐(01763)再涨超8% 近日氟[18F]贝他嗪注射液启动III期临床试验

A股医疗服务板块短线下挫，金凯生科跌超8%，阳光诺和、泰格医药、鸿博医药、贝瑞基因、成都先导跟跌。

泰格、贝达、金斯瑞等投资的Biotech向港交所交表。

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/BK1576/news?page=3"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1576","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1576\",,,,,undefined,":{"symbol":"BK1576","market":"HK","secType":"PLATE","nameCN":"医药外包概念","latestPrice":2031.8922,"timestamp":1749456491226,"preClose":1900.208,"halted":0,"volume":192103157,"delay":0,"changeRate":0.0693,"floatShares":0,"shares":0,"eps":0,"marketStatus":"已收盘","change":131.684204,"latestTime":"06-09 16:00:00","open":1900.3584,"high":2042.7684,"low":1900.3584,"amount":4026060927,"amplitude":0.074944,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1749519000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1749432600000,1749441600000],[1749445200000,1749456000000]],"pbRate":2.188616,"peRate":10.448464,"turnoverRate":0.016637,"increases":7,"decrements":1,"flats":0,"marketCap":432239053312,"floatMarketCap":188258019200},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1576\",,,,,undefined,":{"symbol":"BK1576","high":2042.7684,"amplitude":0.074944,"preClose":1900.208,"low":1900.3584,"pbRate":"2.188616","latestPrice":2031.8922,"volume":192103157,"delay":0,"open":1900.3584,"prevYearClose":1395.7731,"prevWeekClose":1900.208,"prevMonthClose":1859.052,"prevQuarterClose":1941.338,"fiveDayClose":1850.912,"twentyDayClose":1679.686,"sixtyDayClose":1787.578,"secType":"PLATE","market":"HK","turnoverRate":0.016637,"peRate":10.448464,"marketCap":432239053312,"floatMarketCap":188258019200,"timestamp":1749456491226,"nameCN":"医药外包概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1576\",,,,undefined,":{"bkCode":"BK1576","up":7,"down":1,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1576\",pageSize:20,pageCount:3,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2541273030","title":"CXO行业复苏 龙头泰格医药为何“落后”了？","url":"https://stock-news.laohu8.com/highlight/detail?id=2541273030","media":"GPLP犀牛财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541273030?lang=zh_cn&edition=fundamental","pubTime":"2025-06-05 19:28","pubTimestamp":1749122909,"startTime":"0","endTime":"0","summary":"如今在行业复苏浪潮中，泰格医药却成为头部CXO中唯一掉队者。2024年泰格医药营业收入为66.03亿元，同比下降10.58%；净利润为4.05亿元，大幅下跌79.99%，在头部四家企业中垫底。尤其第四季度，泰格医药扣非净亏损为3700万元，同比下滑113.34%。受多重因素影响，泰格医药也采取了应对措施。2024年财报提及，泰格医药新增合同金额101.2亿元，剔除取消订单后的净新增合同84.2亿元，同比增长7.3%；累计待执行合同达157.8亿元，同比增长12.1%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250605192849950fe927&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250605192849950fe927&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1141","03347","BK1576"],"gpt_icon":0},{"id":"2541024987","title":"三生国健：GJ-613新药上市申请获受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2541024987","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541024987?lang=zh_cn&edition=fundamental","pubTime":"2025-06-05 18:48","pubTimestamp":1749120536,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["03347","BK1576","688336","BK4134","BK1583","III","BK0239","BK1141"],"gpt_icon":0},{"id":"2541021276","title":"智飞生物：15价肺炎球菌结合疫苗申请生产注册获受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2541021276","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541021276?lang=zh_cn&edition=fundamental","pubTime":"2025-06-05 18:31","pubTimestamp":1749119474,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK0196","BK0239","LU1328615791.USD","BK0046","BK0077","03347","BK0188","BK1583","LU1064131003.USD","LU2148510915.USD","LU1064130708.USD","LU2580892789.USD","159646","LU2580892862.HKD","300122","BK1576","BK1141"],"gpt_icon":0},{"id":"2541026801","title":"药明生物：授出合共6.41万股受限制股份奖励计划受限制股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2541026801","media":"格隆汇资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541026801?lang=zh_cn&edition=fundamental","pubTime":"2025-06-05 17:37","pubTimestamp":1749116257,"startTime":"0","endTime":"0","summary":"格隆汇6月5日丨药明生物(02269.HK)发布公告，2025年6月5日，董事会已批准授出合共6.41万股受限制股份奖励计划受限制股份，惟须根据受限制股份奖励计划待受限制股份奖励计划承授人接纳，方可作实。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506051737569772cbb4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506051737569772cbb4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0823426480.USD","BK1610","BK1589","LU0516422952.EUR","LU0516422440.USD","LU0516423091.SGD","LU0856984785.SGD","LU0588546209.SGD","LU1794554557.SGD","LU0140636845.USD","LU0052750758.USD","LU1720050803.USD","LU0307460666.USD","LU0708995583.HKD","LU0359201612.USD","LU0516422366.SGD","LU0327786744.USD","LU2039709279.SGD","02269","BK1141","LU0043850808.USD","LU0039217434.USD","LU0572944931.SGD","LU0516423174.USD","LU0417516902.SGD","BK1521","BK1576","LU0359202008.SGD","LU1242518857.USD","LU1880383366.USD","LU0417516738.SGD","LU0456827905.SGD","SG9999002562.SGD","LU0181495838.USD","LU0326950275.SGD","LU0320764599.SGD","LU0348825331.USD","LU1688375341.USD","IE00B0JY6N72.USD","SG9999002463.SGD","LU0456846285.SGD","LU0823426308.USD","LU1242518931.SGD","LU0051755006.USD","LU0819121731.USD","LU0979878070.USD","LU0348735423.USD"],"gpt_icon":0},{"id":"2541023593","title":"药明康德上交所回购47万A股 金额2999万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2541023593","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541023593?lang=zh_cn&edition=fundamental","pubTime":"2025-06-05 17:06","pubTimestamp":1749114372,"startTime":"0","endTime":"0","summary":"药明康德（603259/02359）发布公告，2025年6月5日，在上海证券交易所回购47万A股，总支付金额为2999万元。2025年一季度，药明康德实现收入96.55亿元，归母净利润36.72亿元。文章来源：财中社原标题：药明康德上交所回购47万A股 金额2999万元","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250605171058a6fb81e2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250605171058a6fb81e2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2242644610.SGD","LU1046422090.SGD","LU0708995583.HKD","BK1576","LU2125910500.SGD","BK1583","02359","LU0052750758.USD","BK1141","LU2045819591.USD","LU0320764599.SGD"],"gpt_icon":0},{"id":"2541047983","title":"恒瑞医药：枸橼酸钠血滤置换液获得药品注册批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2541047983","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541047983?lang=zh_cn&edition=fundamental","pubTime":"2025-06-05 16:47","pubTimestamp":1749113243,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["399441","LU1969619763.USD","03347","LU2488822045.USD","LU1064131003.USD","LU0405327494.USD","BK1191","159938","BK1515","BK1574","BK0196","BK0028","BK0183","161726","LU0405327148.USD","BK1583","BK1576","BK0239","09939","600276","LU1064130708.USD","01276","BK0188","BK0060","BK1161","BK0012","BK1141","LU2148510915.USD","LU1328615791.USD","LU2328871848.SGD"],"gpt_icon":0},{"id":"2541047312","title":"福元医药(601089.SH)：酮洛芬贴剂获得药物临床试验批准通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2541047312","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541047312?lang=zh_cn&edition=fundamental","pubTime":"2025-06-05 16:39","pubTimestamp":1749112742,"startTime":"0","endTime":"0","summary":"智通财经APP讯，福元医药(601089.SH)发布公告，近日，公司收到了国家药品监督管理局(简称“国家药监局”)核准签发的酮洛芬贴剂的《药物临床试验批准通知书》。该药品申请适应症：①以下疾病和症状的镇痛、消炎：腰痛(肌肉或筋膜性腰痛、变形性脊椎病、椎间盘疾病、腰椎挫伤)、骨关节炎、肩周炎、肌腱及腱鞘炎、肌腱周围炎、肱骨外上髁炎(网球肘等)、肌肉痛、创伤后肿胀疼痛。②类风湿性关节炎的关节局部镇痛。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1301670.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","BK1576","BK1141","03347","601089","BK1583"],"gpt_icon":0},{"id":"2541042899","title":"舒泰神：注射用STSP-0601纳入优先审评程序","url":"https://stock-news.laohu8.com/highlight/detail?id=2541042899","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541042899?lang=zh_cn&edition=fundamental","pubTime":"2025-06-05 16:27","pubTimestamp":1749112048,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["03347","BK1576","BK0028","159837","300204","BK1583","BK0046","BK0239","BK1141"],"gpt_icon":0},{"id":"2541502911","title":"泰格医药06月05日主力净流出109.2万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2541502911","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541502911?lang=zh_cn&edition=fundamental","pubTime":"2025-06-05 16:15","pubTimestamp":1749111344,"startTime":"0","endTime":"0","summary":"06月05日, 泰格医药股价跌1.38%，报收35.75元，成交金额2.4亿元，换手率5.51%，振幅5.66%，量比1.09。泰格医药今日主力资金净流出109.2万元，上一交易日主力净流入1209.0万元。该股近5个交易日上涨11.54%，主力资金累计净流入660.5万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入2255.9万元，其中净流入天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250605173103a6fb89a7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250605173103a6fb89a7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1141","03347","BK1576"],"gpt_icon":0},{"id":"2541025019","title":"金斯瑞生物科技06月05日主力净流入1827.0万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2541025019","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541025019?lang=zh_cn&edition=fundamental","pubTime":"2025-06-05 16:15","pubTimestamp":1749111339,"startTime":"0","endTime":"0","summary":"06月05日, 金斯瑞生物科技股价涨2.75%，报收13.44元，成交金额4.9亿元，换手率1.65%，振幅6.27%，量比1.58。金斯瑞生物科技今日主力资金净流入1827.0万元，上一交易日主力净流出1133.4万元。该股近5个交易日上涨4.19%，主力资金累计净流入3934.4万元，其中2个交易日为股价下跌时净流入；近20日主力资金累计净流入1.3亿元，其中净流入天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250605172857a49b2ed2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250605172857a49b2ed2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1576","HK0000320264.USD","HK0000306701.USD","HK0000320223.HKD","BK1141","BK1583","01548","HK0000306685.HKD"],"gpt_icon":1},{"id":"2541026887","title":"维亚生物06月05日遭主力抛售223.9万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2541026887","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541026887?lang=zh_cn&edition=fundamental","pubTime":"2025-06-05 16:15","pubTimestamp":1749111320,"startTime":"0","endTime":"0","summary":"06月05日, 维亚生物股价跌2.23%，报收1.75元，成交金额652.9万元，换手率0.17%，振幅6.15%，量比0.83。维亚生物今日主力资金净流出223.9万元，连续3日净流出，上一交易日主力净流出69.5万元。该股近5个交易日下跌6.95%，主力资金累计净流出317.2万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出622.7万元，其中净流出天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250605172109a6fb85dd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250605172109a6fb85dd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","01873","BK1576"],"gpt_icon":0},{"id":"2541047807","title":"中证香港300内地高贝塔指数报917.76点，前十大权重包含药明生物等","url":"https://stock-news.laohu8.com/highlight/detail?id=2541047807","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541047807?lang=zh_cn&edition=fundamental","pubTime":"2025-06-05 16:08","pubTimestamp":1749110935,"startTime":"0","endTime":"0","summary":"数据统计显示，中证香港300内地高贝塔指数近一个月上涨0.13%，近三个月下跌5.08%，年至今上涨9.02%。从中证香港300内地高贝塔指数持仓的市场板块来看，香港证券交易所占比100.00%。从中证香港300内地高贝塔指数持仓样本的行业来看，金融占比23.66%、房地产占比20.89%、医药卫生占比17.74%、可选消费占比16.81%、信息技术占比10.11%、通信服务占比4.16%、原材料占比2.81%、工业占比1.94%、主要消费占比1.89%。特殊情况下将对中证香港策略指数系列进行临时调整。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250605162211a6fb7194&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250605162211a6fb7194&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0516423091.SGD","LU0456827905.SGD","LU0516423174.USD","SG9999002562.SGD","LU0320764599.SGD","BK1610","LU0456846285.SGD","LU1688375341.USD","LU0307460666.USD","LU0823426480.USD","IE00B0JY6N72.USD","SG9999002463.SGD","BK1576","LU0052750758.USD","BK1589","LU0708995583.HKD","LU0856984785.SGD","LU0359202008.SGD","LU0051755006.USD","LU0359201612.USD","LU0516422952.EUR","LU1880383366.USD","LU0181495838.USD","02269","LU0327786744.USD","LU1794554557.SGD","LU0516422366.SGD","LU1242518857.USD","LU0417516738.SGD","LU2039709279.SGD","LU0348825331.USD","LU1242518931.SGD","LU0823426308.USD","LU0572944931.SGD","LU0043850808.USD","BK1141","LU0140636845.USD","LU0348735423.USD","BK1521","LU0979878070.USD","LU0516422440.USD","LU0417516902.SGD","LU0326950275.SGD","LU0588546209.SGD","LU1720050803.USD","LU0819121731.USD","LU0039217434.USD"],"gpt_icon":1},{"id":"2541787048","title":"昭衍新药盘中异动 下午盘大幅跳水5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2541787048","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541787048?lang=zh_cn&edition=fundamental","pubTime":"2025-06-05 13:24","pubTimestamp":1749101089,"startTime":"0","endTime":"0","summary":"2025年06月05日下午盘13时24分，昭衍新药股票出现异动，股价快速下挫5.12%。昭衍新药股票所在的生物技术行业中，整体跌幅为2.71%。消息层面，截至13时24分，《昭衍新药获FIDELITY FUNDS增持781.07万股》资讯为影响昭衍新药的重要信息。该信息摘要如下：根据联交所最新权益披露资料显示，2025年5月30日，昭衍新药获FIDELITY FUNDS在场内以每股均价14.411港元增持781.07万股，涉资约1.13亿港元。增持后，FIDELITY FUNDS最新持股数目为781.07万股，持股比例由0%上升至6.56%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250605132449a6fb3dc4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250605132449a6fb3dc4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1576","BK1141","06127"],"gpt_icon":0},{"id":"2541174710","title":"百奥赛图-B涨超5% 第二代全人IGF-1R抗体NTB003获中国临床试验许可","url":"https://stock-news.laohu8.com/highlight/detail?id=2541174710","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541174710?lang=zh_cn&edition=fundamental","pubTime":"2025-06-05 11:59","pubTimestamp":1749095996,"startTime":"0","endTime":"0","summary":"据悉，NTB003注射液是百奥赛图与南京正大天晴合作开发的第二代全人抗IGF-1R抗体，由百奥赛图基于自主开发的全人抗体RenMab平台完成抗体发现和优化，由南京正大天晴完成CMC工艺开发、GLP安评及IND注册。南京正大天晴将快速推进中国的临床试验及商业化，百奥赛图则将主导该产品海外权益的对外授权许可。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250605120446a6fb2804&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250605120446a6fb2804&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","BK1583","BK1576","03347","02315","BK1161"],"gpt_icon":0},{"id":"2541014602","title":"中银国际：升信达生物目标价至82港元 维持“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2541014602","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541014602?lang=zh_cn&edition=fundamental","pubTime":"2025-06-05 11:11","pubTimestamp":1749093083,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["MUCmain","BK1161","BK1141","01801","03347","BK1589","BK1576","CYB","CNHmain","LU2488822045.USD","MCNHmain","UCmain","LU2328871848.SGD","BK1583","LU1969619763.USD"],"gpt_icon":0},{"id":"2541801169","title":"里昂：和黄医药赛沃替尼研究数据向好 维持“跑赢大市”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2541801169","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541801169?lang=zh_cn&edition=fundamental","pubTime":"2025-06-05 10:41","pubTimestamp":1749091280,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK1191","BK1587","BK4531","BK1141","00013","BK1583","03347","BK1576","BK1588","BK4588","HCM","BK4007","BK4585"],"gpt_icon":0},{"id":"2541201144","title":"美媒称中国生物技术正快速崛起","url":"https://stock-news.laohu8.com/highlight/detail?id=2541201144","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541201144?lang=zh_cn&edition=fundamental","pubTime":"2025-06-05 10:29","pubTimestamp":1749090540,"startTime":"0","endTime":"0","summary":"近期，多家外媒报道称，在全球战略科技竞争加剧的背景下，中国正迅速崛起，成为全球生物技术领域的重要力量，正在重塑全球生物技术的竞争格局。德智库发布报告称，中国在生物技术研发方面投入了大量资金，如今已成为全球生物技术研究强国。美国《时代》杂志5月29日报道称，几十年来，中国政府一直在大力投资生物技术领域。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/t/2025-06-05/doc-ineyyvpe9478812.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["03347","BK1583","BK1576","BK1141"],"gpt_icon":0},{"id":"2541011833","title":"港股异动 | 中国同辐(01763)再涨超8% 近日氟[18F]贝他嗪注射液启动III期临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2541011833","media":"智通财经","labels":["productRelease","movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541011833?lang=zh_cn&edition=fundamental","pubTime":"2025-06-05 10:28","pubTimestamp":1749090507,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，中国同辐再涨超8%，截至发稿，涨7.91%，报14.14港元，成交额1301.32万港元。消息面上，中国同辐附属原子高科发布公告，2025年5月27日，该公司研发的氟[18F]贝他嗪注射液Ⅲ期临床试验首家中心启动会在中国医学科学院北京协和医院成功召开，这标志着该创新药物的临床研究正式进入实质性阶段，为阿尔茨海默病的诊断带来新希望。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1301521.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1576","01763","BK4134","III","BK1583","03347","BK1222","BK1141"],"gpt_icon":0},{"id":"2541015933","title":"A股医疗服务板块短线下挫，金凯生科跌超8%，阳光诺和、泰格医药、鸿博医药、贝瑞基因、成都先导跟跌。","url":"https://stock-news.laohu8.com/highlight/detail?id=2541015933","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541015933?lang=zh_cn&edition=fundamental","pubTime":"2025-06-05 09:37","pubTimestamp":1749087437,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["03347","301509","BK0081","BK0239","BK1141","399300","BK0028","BK0077","BK0221","BK1583","LU1146622755.USD","BK0216","000710","688222","LU1820825898.SGD","BK0042","159982","BK1161","BK0102","BK1515","09939","BK0139","BK1576","BK1574","688621","300347","159938","BK0086","BK0174"],"gpt_icon":0},{"id":"2541601323","title":"泰格、贝达、金斯瑞等投资的Biotech向港交所交表。","url":"https://stock-news.laohu8.com/highlight/detail?id=2541601323","media":"医药财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541601323?lang=zh_cn&edition=fundamental","pubTime":"2025-06-05 09:14","pubTimestamp":1749086077,"startTime":"0","endTime":"0","summary":"根据公开信息，翰思艾泰生物医药科技（武汉）股份有限公司已于2025年6月2日向港交所主板重新递交上市申请，这是继2024年11月首次递表失效后的第二次尝试。总结翰思艾泰二次冲刺港交所，核心看点在于其双抗/融合蛋白技术平台及全球创新管线。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250605091611a6faf304&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250605091611a6faf304&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HK0000320223.HKD","01548","HK0000306701.USD","HK0000306685.HKD","HK0000320264.USD","BK1141","BK1583","BK1576"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":200,"code":"91000000","status":"200"}]}}